Summary: MEL Magazine profiles the late psychedelic chemist Alexander “Sasha” Shulgin, Ph.D., who dedicated decades of his life to synthesizing psychedelic compounds and providing accessible psychedelic education for the masses. Now that psychedelic research is rapidly progressing, including MAPS-sponsored clinical trials of MDMA-assisted therapy for PTSD, “it’s obvious that Shulgin wasn’t merely ahead of his time in the 20th century,” says MEL. “He’s still cutting-edge in 2021.” After Shulgin’s passing, MAPS Founder and Executive Director Rick Doblin, Ph.D., pointed out that “neurochemists and psychopharmacologists recognize the pioneering nature of Sasha’s work.”
Originally appearing here.
